917MO TOPNIVO - A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of head and neck (R/M SCCHN): Final analysis

Authors :: Amaury Daste
G. Lefebvre
A.C. Johnson
A. Prevost
Didier Cupissol
C. Le Tourneau
Isabelle Jallut
Jean Bourhis
J. Fayette
M.C. Kaminski
Sébastien Salas
M. Texier
Caroline Even
Esma Saada-Bouzid
Joël Guigay
Sylvie Zanetta
Elodie Vauleon
Anne Auperin
C. Toullec
Christian Sire
Source :: Annals of Oncology. 31:S662
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Platinum resistance
Internal medicine
Medicine
In patient
Basal cell
Hematology
Nivolumab
business
Head and neck

Tools